Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.080
+0.070 (2.33%)
At close: Aug 7, 2026, 4:00 PM EDT
3.070
-0.010 (-0.32%)
After-hours: Aug 7, 2026, 7:53 PM EDT
Altimmune Market Cap
Altimmune has a market cap or net worth of $598.98 million as of August 7, 2026. Its market cap has increased by 105.14% in one year.
Market Cap
598.98M
Enterprise Value
303.29M
1-Year Change
105.14%
Ranking
Category
Stock Price
$3.08
ChartMarket Cap Chart
Since May 5, 2017, Altimmune's market cap has decreased from $2.19B to $598.98M, a decrease of -72.67%. That is a compound annual growth rate of -13.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 598.98M | 52.01% |
| Dec 31, 2025 | 394.05M | -23.16% |
| Dec 31, 2024 | 512.81M | -15.16% |
| Dec 29, 2023 | 604.45M | -25.23% |
| Dec 30, 2022 | 808.45M | 122.62% |
| Dec 31, 2021 | 363.14M | -12.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MiMedx Group | 632.60M |
| Faeth Therapeutics | 628.74M |
| Nuvectis Pharma | 617.42M |
| ARS Pharmaceuticals | 611.71M |
| Verastem | 592.27M |
| Tectonic Therapeutic | 584.57M |
| CorMedix | 583.68M |
| Arvinas | 572.13M |